Dosage Forms in Drug Delivery: State of the Art and Future Perspectives, 2nd Edition

Dear Colleagues,

The design and optimization of dosage forms play a pivotal role in drug delivery. These dosage forms are very varied, including oral dosage forms (e.g., tablets or capsules), injectable dosage forms (e.g., microparticles, implants, nanoparticles, or liposomes), and topical dosage forms (e.g., patches). These formulations have a significant impact on absorption, distribution, and patient compliance. This Special Issue, entitled "Dosage Forms in Drug Delivery: State of the Art and Future Perspectives, 2nd Edition", aims to provide an in-depth examination of the latest advancements and emerging trends in dosage form design and their implications for drug delivery. It will cover a wide range of topics, including novel formulation approaches, biopharmaceutical considerations, and the use of advanced materials and technologies to enhance drug release, stability, and targeting. The purpose of this Special Issue is to present cutting-edge research and innovations in dosage form design and development, highlighting both current practices and future trends. By bringing together leading experts and emerging voices in the field, this Special Issue aims to foster advancements in formulation science and enhance the precision and effectiveness of drug delivery systems.

We look forward to receiving your contributions. 

Dr. Cristina Martín-Sabroso
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.